SION vs TDG
Sionna Therapeutics, Inc. Common Stock (SION) versus Transdigm Group Incorporated (TDG) — a side-by-side from cached financials, not a winner call.
Sionna Therapeutics, Inc. Common Stock (SION) is a biotechnology company listed on US.
Transdigm Group Incorporated (TDG) is a aerospace & defense company listed on NYSE.
SION does not have a complete income-statement cache yet.
Latest reported TDG revenue for 2025-09-30 was $8.83B. Net income was $2.07B. TDG currently screens at market cap $73.65B and trailing P/E 41.1.
SION currently screens at market cap $0. TDG currently screens at market cap $73.65B and trailing P/E 41.1.
Not investment advice. Open the SION and TDG stock pages for the full models.
Not investment advice.